GNC (NYSE:GNC) Downgraded by ValuEngine to Buy

ValuEngine downgraded shares of GNC (NYSE:GNC) from a strong-buy rating to a buy rating in a report published on Thursday, December 21st.

Other analysts have also issued reports about the company. Barclays lowered their price objective on GNC from $9.00 to $6.00 and set an underweight rating for the company in a report on Friday, October 27th. Robert W. Baird reissued a hold rating and issued a $10.00 price objective on shares of GNC in a report on Sunday, September 17th. Finally, Zacks Investment Research lowered GNC from a hold rating to a strong sell rating in a report on Friday, October 27th. Five investment analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. GNC has an average rating of Hold and a consensus target price of $8.10.

GNC (GNC) remained flat at $$3.72 during trading hours on Thursday. The stock had a trading volume of 5,547,400 shares, compared to its average volume of 3,209,111. The company has a quick ratio of 0.70, a current ratio of 2.44 and a debt-to-equity ratio of -55.95. GNC has a twelve month low of $3.13 and a twelve month high of $11.79. The firm has a market cap of $256.69, a price-to-earnings ratio of -0.68 and a beta of 0.79.

GNC (NYSE:GNC) last released its quarterly earnings results on Thursday, October 26th. The specialty retailer reported $0.32 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.33 by ($0.01). GNC had a negative return on equity of 133.37% and a negative net margin of 15.11%. The business had revenue of $609.47 million during the quarter, compared to analyst estimates of $614.08 million. During the same quarter last year, the firm posted $0.59 EPS. The company’s revenue was down 2.9% compared to the same quarter last year. equities research analysts expect that GNC will post 1.28 earnings per share for the current fiscal year.

In other GNC news, EVP Tim Mantel acquired 20,000 shares of GNC stock in a transaction dated Friday, November 10th. The stock was acquired at an average cost of $5.80 per share, for a total transaction of $116,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.85% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of GNC. Bayesian Capital Management LP acquired a new position in shares of GNC during the second quarter worth approximately $102,000. Quantitative Systematic Strategies LLC acquired a new position in shares of GNC during the third quarter worth approximately $109,000. WFG Advisors LP boosted its position in shares of GNC by 13.1% during the second quarter. WFG Advisors LP now owns 14,773 shares of the specialty retailer’s stock worth $125,000 after buying an additional 1,715 shares during the period. Sii Investments Inc. WI boosted its position in shares of GNC by 22.5% during the second quarter. Sii Investments Inc. WI now owns 23,268 shares of the specialty retailer’s stock worth $196,000 after buying an additional 4,268 shares during the period. Finally, Comerica Bank lifted its position in GNC by 6.7% in the second quarter. Comerica Bank now owns 22,443 shares of the specialty retailer’s stock worth $201,000 after purchasing an additional 1,419 shares during the period. Institutional investors and hedge funds own 61.81% of the company’s stock.

TRADEMARK VIOLATION WARNING: “GNC (NYSE:GNC) Downgraded by ValuEngine to Buy” was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this piece of content can be viewed at https://ledgergazette.com/2018/01/16/valuengine-lowers-gnc-gnc-to-buy.html.

About GNC

GNC Holdings, Inc is a specialty retailer of health, wellness and performance products, which include protein, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty, food and drink and other general merchandise. The Company’s operations consist of purchasing raw materials, formulating and manufacturing products and selling the finished products.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for GNC (NYSE:GNC)

Receive News & Ratings for GNC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GNC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply